Radnor’s ControlRad Systems Raises $3 Million Ahead of Debut Product Launch

New eye-tracking radiation technology is catching the eyes of medical device investors, as Radnor’s ControlRad Systems just generated $3 million from the sale of private stock.

The funding gets ControlRad halfway to its $6 million goal as it prepares for the launch of its debut product, according to a Philadelphia Business Journal report by John George.

The company specializes in reduced-radiation imaging for fluoroscopic medical procedures using eye-tracking technology.

“Doctors, by where they look, tell the radiation where it needs to go,” said Drexel University Professor Alion Guez.

ControlRad asserted in a 2016 Medical Physics-published study that its technology exposed patients to 75 percent less radiation without affecting the procedure’s performance.

“The risks of radiation exposure during interventional x-ray procedures to both patients and the medical staff are well documented,” said lead author Stephen Balter. “These results demonstrate a novel approach to dramatically reducing the radiation exposure.”

Read more about ControlRad’s eye-tracking radiation technology and its stock sale in the Philadelphia Business Journal here.